Written by : Dr. Aishwarya Sarthe
February 27, 2024
This collaboration aims to leverage advanced technology and expertise to improve patient outcomes and revolutionize cardiac care.
Switzerland-based SmartCardia, a leading provider of cardiac monitoring solutions, has joined forces with Kokilaben Dhirubhai Ambani Hospital (KDAH) to bolster the treatment and management of cardiac arrhythmia.
This collaboration aims to leverage advanced technology and expertise to improve patient outcomes and revolutionize cardiac care.
This partnership was announced during a session for healthcare professionals focused on the "Role of AI in Cardiology and Healthcare" held at Kokilaben Dhirubhai Ambani Hospital recently. Sharing insights, Dr Jag Singh, professor of medicine at Harvard Medical School & Principal Advisor for SmartCardia, said, "Collaborating with Kokilaben Dhirubhai Ambani Hospital marks a significant step towards advancing cardiac arrhythmia care. Together with KDAH, SmartCardia aims to leverage artificial intelligence and transformative technologies to revolutionize patient care, ensuring a brighter and healthier future for all."
A key highlight of the collaboration is the introduction of the SmartCardia 7L patch, a breakthrough in cardiac monitoring technology. This patch enables real-time transmission of electrocardiogram (ECG) data and multiple vital signs, facilitating early detection of severe cardiac arrhythmia conditions.
Unlike traditional monitoring devices, the SmartCardia 7L patch offers cable-free, easy-to-wear functionality, allowing for continuous monitoring for up to two weeks. This innovation empowers healthcare professionals with immediate access to critical patient data, enabling timely interventions and personalized treatment plans.
In an exclusive conversation with DHN, Srinivasan Murali, the founder of SmartCardia, shed light on the distinguishing features of the SmartCardia 7L patch.
He said, "SmartCardia's 7L is a cable-free, easy-to-wear patch that continuously monitors a patient's ECG and vitals for up to two weeks. Thanks to highly accurate multi-lead ECG, continuous monitoring, cutting-edge AI, and real-time monitoring, SmartCardia can detect heart rhythm abnormalities accurately and quickly."
Murali highlighted how the real-time transmission of ECG and vital signs through the SmartCardia 7L patch improves the efficiency of healthcare professionals and benefits patients.
He said, "Today's cardiac screening and monitoring solutions are ineffective in detecting heart rhythm problems early on. SmartCardia's 7L patch monitoring detects cardiac rhythm problems accurately, notifying clinicians and healthcare staff quickly. It covers the entire spectrum of monitoring: from screening to hospital ward monitoring and post-discharge home monitoring, resembling an ICU in the form of a wearable patch."
Moreover, Murali elaborated on the proactive alert system implemented by SmartCardia, highlighting its role in reducing response times to cardiac episodes and improving patient outcomes.
He said, "Our AI software sifts through the live data transmitted from the patch and detects the problem immediately, notifying the clinician. With KDA, we are working closely to predict heart health deterioration days to months ahead of the actual problem happening."
Discussing the broader implications of the collaboration, Murali emphasized the potential for global advancement in cardiac arrhythmia care. He added, "Switzerland's focus on precision R&D, combined with the clinical expertise of top doctors at KDA, will enable the development of state-of-the-art cardiac care solutions. Close collaboration between our principal advisor, Dr Jag Singh from Harvard Medical School/MGH, KDA, and SmartCardia will facilitate a global advancement of cardiac care."
SmartCardia's cloud SaaS platform, founded by Srinivasan Murali and Francisco Rincón in 2015, offers a single solution for complete cardiology practice and remote patient monitoring. With its cutting-edge technology, SmartCardia’s ECG patch offers superior accuracy in detecting cardiac arrhythmias, supported by seven ECG leads and advanced features such as exceptional P-wave and QRS beat morphology.
Powered by SmartCardia's SmartNeuralNet, a machine learning technology, the system ensures prompt notification to clinicians during a cardiac arrhythmia or patient deterioration, facilitating proactive interventions and enhancing patient care.